14-3-4 ⓔ文献

  1. 日本透析医学会編:わが国の慢性透析療法の現況 2018年12月31日現在,2019.

  2. 循環器病予防研究会監:第5次循環器疾患基礎調査結果,中央法規出版,2003.

  3. Yamagata K, Iseki K, et al: Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol, 2008; 12: 1–8.

  4. Cameron JS: Proteinuria and progression in human glomerular diseases. Am J Nephrol, 1990; 1: 81–87.

  5. Burton C, Harris KPG: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis, 1996; 27: 765–775.

  6. Usui J, Yamagata K, et al: Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. Intern Med, 2001; 40: 697–702.

  7. Abbate M, Zoja C, et al: How does proteinuria cause progressive renal damage? J Am Soc Nephrol, 2006; 17: 2974–2984.

  8. Hostetter TH, Brenner BM, et al: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol, 1981; 241: F85–93.

  9. Brenner BM, Meyer T W, et al: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med, 1982; 307: 652–659.